Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15374946)

  • 1. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer.
    Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW
    Cancer Res; 2004 Sep; 64(18):6394-401. PubMed ID: 15374946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
    Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
    Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis.
    Papanikolaou A; Wang QS; Papanikolaou D; Whiteley HE; Rosenberg DW
    Carcinogenesis; 2000 Aug; 21(8):1567-72. PubMed ID: 10910960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
    Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxycholic acid promotes the growth of colonic aberrant crypt foci.
    Flynn C; Montrose DC; Swank DL; Nakanishi M; Ilsley JN; Rosenberg DW
    Mol Carcinog; 2007 Jan; 46(1):60-70. PubMed ID: 17091474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of PPARbeta/delta and cyclin D1 in flat dysplastic ACF and adenomas in Apc(Min/+) mice.
    Knutsen HK; Olstørn HB; Paulsen JE; Husøy T; Goverud IL; Løberg EM; Kristiansen K; Alexander J
    Anticancer Res; 2005; 25(6B):3781-9. PubMed ID: 16309164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
    Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strain-specific homeostatic responses during early stages of Azoxymethane-induced colon tumorigenesis in mice.
    Guda K; Marino JN; Jung Y; Crary K; Dong M; Rosenberg DW
    Int J Oncol; 2007 Oct; 31(4):837-42. PubMed ID: 17786315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azoxymethane induces KI-ras activation in the tumor resistant AKR/J mouse colon.
    Bolt AB; Papanikolaou A; Delker DA; Wang QS; Rosenberg DW
    Mol Carcinog; 2000 Mar; 27(3):210-8. PubMed ID: 10708483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-catenin expression is altered in human colonic aberrant crypt foci.
    Hao XP; Pretlow TG; Rao JS; Pretlow TP
    Cancer Res; 2001 Nov; 61(22):8085-8. PubMed ID: 11719432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer.
    Bird RP
    Cancer Lett; 1995 Jun; 93(1):55-71. PubMed ID: 7600544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correspondence between flat aberrant crypt foci and mucin-depleted foci in rodent colon carcinogenesis.
    Femia AP; Paulsen JE; Dolara P; Alexander J; Caderni G
    Anticancer Res; 2008; 28(6A):3771-5. PubMed ID: 19189663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant crypt foci.
    Alrawi SJ; Schiff M; Carroll RE; Dayton M; Gibbs JF; Kulavlat M; Tan D; Berman K; Stoler DL; Anderson GR
    Anticancer Res; 2006; 26(1A):107-19. PubMed ID: 16475686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of aberrant crypt foci by chemopreventive agents.
    Olivo S; Wargovich MJ
    In Vivo; 1998; 12(2):159-66. PubMed ID: 9627797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of flat dysplastic aberrant crypt foci in the colon of azoxymethane-treated A/J mice.
    Paulsen JE; Knutsen H; Ølstørn HB; Løberg EM; Alexander J
    Int J Cancer; 2006 Feb; 118(3):540-6. PubMed ID: 16094649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flat dysplastic aberrant crypt foci are related to tumorigenesis in the colon of azoxymethane-treated rat.
    Paulsen JE; Løberg EM; Olstørn HB; Knutsen H; Steffensen IL; Alexander J
    Cancer Res; 2005 Jan; 65(1):121-9. PubMed ID: 15665287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer.
    Luo L; Shen GQ; Stiffler KA; Wang QK; Pretlow TG; Pretlow TP
    Carcinogenesis; 2006 Jun; 27(6):1153-9. PubMed ID: 16474178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Matsunaga K; Katayama M; Sakata K; Shimizu M; Kuno T; Mori H
    Cancer Res; 2001 Mar; 61(5):1874-8. PubMed ID: 11280741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary iron promotes azoxymethane-induced colon tumors in mice.
    Ilsley JN; Belinsky GS; Guda K; Zhang Q; Huang X; Blumberg JB; Milbury PE; Roberts LJ; Stevens RG; Rosenberg DW
    Nutr Cancer; 2004; 49(2):162-9. PubMed ID: 15489209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic/knockout progenitors.
    Nambiar PR; Girnun G; Lillo NA; Guda K; Whiteley HE; Rosenberg DW
    Int J Oncol; 2003 Jan; 22(1):145-50. PubMed ID: 12469197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.